BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21775922)

  • 1. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
    Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
    Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
    Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
    Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.
    Hims MM; Ibrahim EC; Leyne M; Mull J; Liu L; Lazaro C; Shetty RS; Gill S; Gusella JF; Reed R; Slaugenhaupt SA
    J Mol Med (Berl); 2007 Feb; 85(2):149-61. PubMed ID: 17206408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific correction of a splice defect in brain by nutritional supplementation.
    Shetty RS; Gallagher CS; Chen YT; Hims MM; Mull J; Leyne M; Pickel J; Kwok D; Slaugenhaupt SA
    Hum Mol Genet; 2011 Nov; 20(21):4093-101. PubMed ID: 21821670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.
    Hervé M; Ibrahim EC
    Neurobiol Dis; 2017 Jul; 103():113-122. PubMed ID: 28404519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells.
    Boone N; Bergon A; Loriod B; Devèze A; Nguyen C; Axelrod FB; Ibrahim EC
    Hum Mutat; 2012 Mar; 33(3):530-40. PubMed ID: 22190446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
    Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
    Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation.
    Lefler S; Cohen MA; Kantor G; Cheishvili D; Even A; Birger A; Turetsky T; Gil Y; Even-Ram S; Aizenman E; Bashir N; Maayan C; Razin A; Reubinoff BE; Weil M
    PLoS One; 2015; 10(10):e0138807. PubMed ID: 26437462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
    Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
    Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice.
    Sinha R; Kim YJ; Nomakuchi T; Sahashi K; Hua Y; Rigo F; Bennett CF; Krainer AR
    Nucleic Acids Res; 2018 Jun; 46(10):4833-4844. PubMed ID: 29672717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of a human mRNA splicing defect by the plant cytokinin kinetin.
    Slaugenhaupt SA; Mull J; Leyne M; Cuajungco MP; Gill SP; Hims MM; Quintero F; Axelrod FB; Gusella JF
    Hum Mol Genet; 2004 Feb; 13(4):429-36. PubMed ID: 14709595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia.
    Boone N; Loriod B; Bergon A; Sbai O; Formisano-Tréziny C; Gabert J; Khrestchatisky M; Nguyen C; Féron F; Axelrod FB; Ibrahim EC
    PLoS One; 2010 Dec; 5(12):e15590. PubMed ID: 21187979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
    Cuajungco MP; Leyne M; Mull J; Gill SP; Lu W; Zagzag D; Axelrod FB; Maayan C; Gusella JF; Slaugenhaupt SA
    Am J Hum Genet; 2003 Mar; 72(3):749-58. PubMed ID: 12577200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
    Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
    Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
    Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients.
    Yannai S; Zonszain J; Donyo M; Ast G
    PLoS One; 2019; 14(3):e0211602. PubMed ID: 30889183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia.
    Salani M; Urbina F; Brenner A; Morini E; Shetty R; Gallagher CS; Law EA; Sunshine S; Finneran DJ; Johnson G; Minor L; Slaugenhaupt SA
    SLAS Discov; 2019 Jan; 24(1):57-67. PubMed ID: 30085848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.
    Anderson SL; Qiu J; Rubin BY
    Biochem Biophys Res Commun; 2003 Jun; 306(1):303-9. PubMed ID: 12788105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.
    Hims MM; Shetty RS; Pickel J; Mull J; Leyne M; Liu L; Gusella JF; Slaugenhaupt SA
    Genomics; 2007 Sep; 90(3):389-96. PubMed ID: 17644305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.
    Keren H; Donyo M; Zeevi D; Maayan C; Pupko T; Ast G
    PLoS One; 2010 Dec; 5(12):e15884. PubMed ID: 21209961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.